Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

8.85
Delayed Data
As of Oct 17
 -0.16 / -1.78%
Today’s Change
8.16
Today|||52-Week Range
14.22
-15.39%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close9.01
Today’s open8.99
Day’s range8.80 - 9.05
Volume54,576
Average volume (3 months)96,210
Market cap$154.8M
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...-0.20-10.26%
REPHRecro Pharma Inc+0.06+0.69%
TRVNTrevena Inc-0.29-13.62%
VCELVericel Corp-0.10-2.13%
Data as of 10/17/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts